Treatment Options for Childhood Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Juvenile Myelomonocytic Leukemia
Treatment of myelodysplastic syndromes (MDS) may include the following:
- Watchful waiting.
- Stem cell transplant.
- Combination chemotherapy.
- Lenalidomide therapy.
- A clinical trial of stem cell transplant using lower doses of chemotherapy.
- A clinical trial of a new anticancer drug or targeted therapy.
Supportive care treatments are used to manage problems caused by the disease, such as infection, bleeding, and anemia.
If the MDS progresses to acute myeloid leukemia (AML), treatment will be the same as treatment for the newly diagnosed patient with AML.
Treatment of therapy-related MDS is usually the same as for newly diagnosed AML, followed by stem cell transplant.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with childhood myelodysplastic syndromes. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.